Shares of Chemed Corp. (NYSE:CHE) gapped up prior to trading on Friday . The stock had previously closed at $134.61, but opened at $135.26. Chemed Corp. shares last traded at $137.33, with a volume of 15,166 shares changing hands.

A number of analysts have issued reports on CHE shares. Zacks Investment Research raised Chemed Corp. from a “sell” rating to a “hold” rating in a research report on Tuesday, April 19th. Royal Bank Of Canada reissued a “sector perform” rating and issued a $136.00 target price (up previously from $135.00) on shares of Chemed Corp. in a research report on Monday, May 2nd. Finally, Oppenheimer Holdings Inc. reissued a “buy” rating on shares of Chemed Corp. in a research report on Saturday, April 30th.

The firm has a market capitalization of $2.28 billion and a price-to-earnings ratio of 21.54. The company has a 50-day moving average of $132.63 and a 200-day moving average of $134.87.

Chemed Corp. (NYSE:CHE) last released its quarterly earnings results on Thursday, April 28th. The company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.58 by $0.04. The business earned $390.40 million during the quarter, compared to analyst estimates of $391.68 million. During the same quarter in the prior year, the company earned $1.54 earnings per share. The firm’s revenue for the quarter was up 3.6% compared to the same quarter last year. Analysts forecast that Chemed Corp. will post $7.18 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, June 15th. Stockholders of record on Thursday, May 26th were given a $0.24 dividend. The ex-dividend date of this dividend was Tuesday, May 24th. This represents a $0.96 annualized dividend and a dividend yield of 0.70%.

A number of hedge funds have recently made changes to their positions in the company. Dimensional Fund Advisors LP raised its stake in shares of Chemed Corp. by 8.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 370,170 shares of the company’s stock worth $55,453,000 after buying an additional 29,461 shares during the period. Advisors Asset Management Inc. raised its stake in shares of Chemed Corp. by 6.0% in the fourth quarter. Advisors Asset Management Inc. now owns 26,094 shares of the company’s stock worth $3,909,000 after buying an additional 1,470 shares during the period. Schroder Investment Management Group raised its stake in shares of Chemed Corp. by 127.8% in the fourth quarter. Schroder Investment Management Group now owns 254,400 shares of the company’s stock worth $38,109,000 after buying an additional 142,700 shares during the period. Principal Financial Group Inc. raised its stake in shares of Chemed Corp. by 5.3% in the fourth quarter. Principal Financial Group Inc. now owns 114,771 shares of the company’s stock worth $17,193,000 after buying an additional 5,812 shares during the period. Finally, Wells Fargo & Company MN raised its stake in shares of Chemed Corp. by 1.8% in the fourth quarter. Wells Fargo & Company MN now owns 47,265 shares of the company’s stock worth $7,081,000 after buying an additional 844 shares during the period.

Chemed Corporation (Chemed) purchases, operates and divests subsidiaries engaged in diverse business activities. The Company operates its business in two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.